Amwill Health Care Limited (BOM:544353)
44.00
+2.36 (5.67%)
At close: Nov 6, 2026
Amwill Health Care Revenue
Amwill Health Care had revenue of 226.29M INR in the half year ending September 30, 2026, a decrease of -2.28%. This brings the company's total for the last twelve months to 469.16M, up 21.45% year-over-year. In the fiscal year ending March 31, 2026, Amwill Health Care had annual revenue of 454.92M with 12.10% growth. That makes Amwill Health Care the 40,012th largest company in the world by revenue and 3,823rd in India.
Revenue (ttm)
469.16M
Revenue Growth
+21.45%
P/S Ratio
1.88
Revenue / Employee
5.33M
Employees
88
Market Cap
880.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 454.92M | 49.11M | 12.10% |
| Mar 31, 2025 | 405.82M | -33.67M | -7.66% |
| Mar 31, 2024 | 439.48M | 137.82M | 45.69% |
| Mar 31, 2023 | 301.66M | 25.53M | 9.25% |
| Mar 31, 2022 | 276.13M | 96.14M | 53.41% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Parnax Lab | 2.52B |
| Godavari Drugs | 1.11B |
| Concord Drugs | 860.69M |
| Source Natural Foods and Herbal Supplements | 796.24M |
| Mercury Laboratories | 732.23M |
| Shelter Pharma | 731.34M |
| Cian Healthcare | 282.99M |
| Pharmaids Pharmaceuticals | 253.40M |